Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 53 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 9376448

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  2. US 9375438

    Inhibitors of NCCa-ATP channels for therapy

    The United States of America as Represented by the Dept. of Veterans Affairs · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  3. US 9370519

    Macrocyclic FLT3 kinase inhibitors

    Oncodesign SA · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  4. US 9371337

    β-lactamase inhibitors

    The Regents of the University of California · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  5. US 9370505

    Pharmaceutical compositions comprising an aromatse inhibitors

    MEREO BIOPHARMA 2 LIMITED · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  6. US 9365602

    Sodium glucose co-transporter inhibitors and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  7. US 9365549

    Hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  8. US 9365557

    Substituted pyrazin-2-amines as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  9. US 9365612

    Caspase inhibitors

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  10. US 9359418

    Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  11. US 9359309

    Synthesis of syrbactin proteasome inhibitors

    The Regents of the University of California · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  12. US 9359380

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  13. US 9353107

    3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors

    Aurigene Discovery Technologies Limited · Granted May 31, 2016 · Expires May 26, 2036

    granted
  14. US 9353075

    Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)

    The Regents of the University of California · Granted May 31, 2016 · Expires May 26, 2036

    granted
  15. US 9353124

    Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  16. US 9353126

    Substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  17. US 9353094

    Substituted quinoxalines as kinase inhibitors

    The Board of Regents of the University of Texas System · Granted May 31, 2016 · Expires May 26, 2036

    granted
  18. US 9345708

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted May 24, 2016 · Expires May 19, 2036

    granted
  19. US 9345713

    6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

    Takeda Pharmaceutical Company Limited · Granted May 24, 2016 · Expires May 19, 2036

    granted
  20. US 9340547

    Pyrrolotriazinone derivatives as inhibitors P13K

    Almirall, S.A. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  21. US 9340557

    Substituted quinoxaline DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 17, 2016 · Expires May 12, 2036

    granted
  22. US 9340546

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted May 17, 2016 · Expires May 12, 2036

    granted
  23. US 9340522

    Pyrazolone-derivatives and their use as PDE-4 inhibitors

    TAKEDA GMBH · Granted May 17, 2016 · Expires May 12, 2036

    granted
  24. US 9334245

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted May 10, 2016 · Expires May 5, 2036

    granted